- Leerink Partners 6th Annual Global Healthcare Conference on February 16 in New York City
- Cowen and Company 37th Annual Health Care Conference on March 7 in Boston
- Barclays Global Healthcare Conference on March 15 in Miami
SAN RAFAEL, Calif., Feb. 8, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. BMRN, today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the Leerink Partners 6th Annual Global Healthcare Conference on February 16, 2017 at 1:00pm ET, in New York City. Management will also participate in the Cowen and Company 37th Annual Health Care Conference on March 7, 2017 at 11:20am ET in Boston and the Barclays Global Healthcare Conference on March 15, 2017 at 8:00am ET, in Miami. To access the live webcasts, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of five commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.
Contacts: |
|
Investors |
Media |
Traci McCarty |
Debra Charlesworth |
BioMarin Pharmaceutical Inc. |
BioMarin Pharmaceutical Inc. |
(415) 455-7558 |
(415) 455-7451 |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biomarin-to-attend-three-investor-conferences-in-1q17-300402955.html
SOURCE BioMarin Pharmaceutical Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.